{"pmid":32433784,"title":"High Fluorescent Lymphocytes Are Increased in COVID-19 Patients.","text":["High Fluorescent Lymphocytes Are Increased in COVID-19 Patients.","Since the outbreak of SARS-CoV-2 in December 2019, the etiology of Coronavirus Disease 2019 (COVID-19) has spread to most of the world within months. The understanding of pathomechanism of SARS-CoV-2 is extremely limited.","Br J Haematol","Wang, Zhao","He, Yu","Shu, Huaqing","Wang, Ping","Xing, Hui","Zeng, Xiaoqian","Tang, Zhaoming","32433784"],"abstract":["Since the outbreak of SARS-CoV-2 in December 2019, the etiology of Coronavirus Disease 2019 (COVID-19) has spread to most of the world within months. The understanding of pathomechanism of SARS-CoV-2 is extremely limited."],"journal":"Br J Haematol","authors":["Wang, Zhao","He, Yu","Shu, Huaqing","Wang, Ping","Xing, Hui","Zeng, Xiaoqian","Tang, Zhaoming"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32433784","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/bjh.16867","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667342288111534080,"score":9.490897,"similar":[{"pmid":32321823,"pmcid":"PMC7178552","title":"COVID-19: an Immunopathological View.","text":["COVID-19: an Immunopathological View.","Since its emergence in December 2019, it took only a couple of months for an outbreak of the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World Health Organization (WHO). This along with the highly infectious nature of the disease and the associated mortality call for particular attention to the underlying (immuno)pathomechanism(s). The latter will inform case management and vaccine design. Unravelling these mechanisms can assist basic scientists, laboratory medicine practitioners, clinicians, public health practitioners, funding agencies, and health care policymakers in responding to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.","mSphere","Kadkhoda, Kamran","32321823"],"abstract":["Since its emergence in December 2019, it took only a couple of months for an outbreak of the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World Health Organization (WHO). This along with the highly infectious nature of the disease and the associated mortality call for particular attention to the underlying (immuno)pathomechanism(s). The latter will inform case management and vaccine design. Unravelling these mechanisms can assist basic scientists, laboratory medicine practitioners, clinicians, public health practitioners, funding agencies, and health care policymakers in responding to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic."],"journal":"mSphere","authors":["Kadkhoda, Kamran"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32321823","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1128/mSphere.00344-20","keywords":["covid-19","sars-cov-2","immunopathology"],"topics":["Mechanism"],"weight":1,"_version_":1666138493765550081,"score":82.663704},{"pmid":32238757,"title":"Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).","text":["Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).","Coronavirus disease 2019 (COVID-19), which causes serious respiratory illness such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei, China. The etiological agent of COVID-19 has been confirmed as a novel coronavirus, now known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is most likely originated from zoonotic coronaviruses, like SARS-CoV, which emerged in 2002. Within a few months of the first report, SARS-CoV-2 had spread across China and worldwide, reaching a pandemic level. As COVID-19 has triggered enormous human casualties and serious economic loss posing global threat, an understanding of the ongoing situation and the development of strategies to contain the virus's spread are urgently needed. Currently, various diagnostic kits to test for COVID-19 are available and several repurposing therapeutics for COVID-19 have shown to be clinically effective. In addition, global institutions and companies have begun to develop vaccines for the prevention of COVID-19. Here, we review the current status of epidemiology, diagnosis, treatment, and vaccine development for COVID-19.","J Microbiol Biotechnol","Ahn, Dae-Gyun","Shin, Hye-Jin","Kim, Mi-Hwa","Lee, Sunhee","Kim, Hae-Soo","Myoung, Jinjong","Kim, Bum-Tae","Kim, Seong-Jun","32238757"],"abstract":["Coronavirus disease 2019 (COVID-19), which causes serious respiratory illness such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei, China. The etiological agent of COVID-19 has been confirmed as a novel coronavirus, now known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is most likely originated from zoonotic coronaviruses, like SARS-CoV, which emerged in 2002. Within a few months of the first report, SARS-CoV-2 had spread across China and worldwide, reaching a pandemic level. As COVID-19 has triggered enormous human casualties and serious economic loss posing global threat, an understanding of the ongoing situation and the development of strategies to contain the virus's spread are urgently needed. Currently, various diagnostic kits to test for COVID-19 are available and several repurposing therapeutics for COVID-19 have shown to be clinically effective. In addition, global institutions and companies have begun to develop vaccines for the prevention of COVID-19. Here, we review the current status of epidemiology, diagnosis, treatment, and vaccine development for COVID-19."],"journal":"J Microbiol Biotechnol","authors":["Ahn, Dae-Gyun","Shin, Hye-Jin","Kim, Mi-Hwa","Lee, Sunhee","Kim, Hae-Soo","Myoung, Jinjong","Kim, Bum-Tae","Kim, Seong-Jun"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238757","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.4014/jmb.2003.03011","keywords":["2019-ncov","covid-19","sars-cov-2","coronavirus","outbreak"],"locations":["Wuhan","Hubei","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138490233946113,"score":66.11887},{"pmid":32366746,"title":"Guidance for the management of adult patients with coronavirus disease 2019.","text":["Guidance for the management of adult patients with coronavirus disease 2019.","In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the available data and anti-epidemic experience in China.","Chin Med J (Engl)","Qu, Jie-Ming","Wang, Chen","Cao, Bin","32366746"],"abstract":["In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the available data and anti-epidemic experience in China."],"journal":"Chin Med J (Engl)","authors":["Qu, Jie-Ming","Wang, Chen","Cao, Bin"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32366746","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1097/CM9.0000000000000899","locations":["Wuhan","Hubei","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1666138496119603200,"score":65.681786},{"pmid":32483300,"title":"SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine \"storm\" and risk factor for damage of hematopoietic stem cells.","text":["SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine \"storm\" and risk factor for damage of hematopoietic stem cells.","The scientific community faces an unexpected and urgent challenge related to the SARS-CoV-2 pandemic and is investigating the role of receptors involved in entry of this virus into cells as well as pathomechanisms leading to a cytokine \"storm,\" which in many cases ends in severe acute respiratory syndrome, fulminant myocarditis and kidney injury. An important question is if it may also damage hematopoietic stem progenitor cells?","Leukemia","Ratajczak, Mariusz Z","Kucia, Magda","32483300"],"abstract":["The scientific community faces an unexpected and urgent challenge related to the SARS-CoV-2 pandemic and is investigating the role of receptors involved in entry of this virus into cells as well as pathomechanisms leading to a cytokine \"storm,\" which in many cases ends in severe acute respiratory syndrome, fulminant myocarditis and kidney injury. An important question is if it may also damage hematopoietic stem progenitor cells?"],"journal":"Leukemia","authors":["Ratajczak, Mariusz Z","Kucia, Magda"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32483300","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1038/s41375-020-0887-9","topics":["Treatment","Mechanism"],"weight":1,"_version_":1668532114877841409,"score":65.55316},{"pmid":32347067,"title":"[Optimization of a fluorescent qPCR detection for RNA of SARS-CoV-2].","text":["[Optimization of a fluorescent qPCR detection for RNA of SARS-CoV-2].","We optimized a fluorescent quantitative polymerase chain reaction (qPCR) assay system for rapid and real time detection of SARS-CoV-2 RNA. The results show that the lowest dilution of RNA samples used for the detection of SARS-CoV-2 RNA could reach 1/10 000 (the initial value is set as 10 ng/muL). Moreover, the cycle threshold (Ct) for samples of clinically diagnosed COVID-19 was lower than 35 or 40. The sensitivity of this method was satisfactory. The results were consistent with those of the COVID-19 detection kit on the market under the same conditions, but the number of cycles required was shortened by about 2. Therefore, the optimized assay developed in this study can be used in screening and early clinical diagnosis. Our work provides a tool to facilitate rapid clinical diagnosis of COVID-19.","Sheng Wu Gong Cheng Xue Bao","Li, Xuelong","Liu, Junhua","Liu, Qianyang","Yu, Lin","Wu, Shanshan","Yin, Xiushan","32347067"],"abstract":["We optimized a fluorescent quantitative polymerase chain reaction (qPCR) assay system for rapid and real time detection of SARS-CoV-2 RNA. The results show that the lowest dilution of RNA samples used for the detection of SARS-CoV-2 RNA could reach 1/10 000 (the initial value is set as 10 ng/muL). Moreover, the cycle threshold (Ct) for samples of clinically diagnosed COVID-19 was lower than 35 or 40. The sensitivity of this method was satisfactory. The results were consistent with those of the COVID-19 detection kit on the market under the same conditions, but the number of cycles required was shortened by about 2. Therefore, the optimized assay developed in this study can be used in screening and early clinical diagnosis. Our work provides a tool to facilitate rapid clinical diagnosis of COVID-19."],"journal":"Sheng Wu Gong Cheng Xue Bao","authors":["Li, Xuelong","Liu, Junhua","Liu, Qianyang","Yu, Lin","Wu, Shanshan","Yin, Xiushan"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347067","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.13345/j.cjb.200088","keywords":["covid-19","n gene","orf1a gene","sars-cov-2","fluorescence real-time quantitative pcr"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494967218176,"score":63.74181}]}